
    
      The primary objective of this study is to evaluate the safety of GCS-100, and effect of
      GCS-100 on markers of apoptosis in subjects with chronic lymphocytic leukemia. The secondary
      objective of this study is to evaluate the effect of GCS-100 on peripheral blood leukocyte
      count in subjects with chronic lymphocytic leukemia.
    
  